Physician

Jaswinder Singh, MD

According to 2025 Medicare claims, Jaswinder Singh, MD (NPI: 1093747677) practices hematology/oncology in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Jackson, MO. This provider's primary affiliated billing organization is AMERICAN ONCOLOGY PARTNERS PA (NPI: 1265929723; TIN: 824681345) and primary practice location at 64132-9998. Singh is affiliated with the Centrus Health LLC (ACO ID: A5304), participating under the MSSP model.

Singh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,281 traditional Medicare patients, billed 4,864 HCPCS/CPT codes, and received $308,828 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 6,497 prescription claims across 1,001 beneficiaries totaling $10,541,171 in drug costs, led by Revlimid (Lenalidomide). DME data shows 119 claims. Open Payments data shows 300 records totaling $743,319. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $3,752,967 to $10,541,171. For DME billing, reported payments did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	760	5,164	$297,185
2016	746	4,878	$289,054
2017	761	5,110	$288,663
2018	812	4,012	$213,446
2019	921	4,685	$234,228
2020	976	4,280	$240,843
2021	1,064	4,039	$285,082
2022	1,183	3,866	$275,739
2023	1,067	3,597	$242,919
2024	1,281	4,864	$308,828

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	517	4,961	$3,752,967
2016	509	5,365	$3,794,491
2017	527	5,267	$4,149,034
2018	520	4,759	$3,918,396
2019	606	4,927	$5,137,819
2020	626	4,860	$6,762,921
2021	717	4,551	$6,823,378
2022	796	4,790	$4,685,595
2023	848	5,089	$6,873,736
2024	1,001	6,497	$10,541,171

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	136	550	$138,825
2016	65	334	$82,896
2017	15	218	$33,939
2018	36	128	$15,704
2019	77	310	$31,302
2020	78	353	$25,219
2021	57	233	$17,089
2022	61	192	$7,938
2023	25	95	$21,421
2024	25	119	$140,377

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	121	139	$127
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	169	434	$88
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	907	1,779	$69
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	144	467	$59
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	214	232	$46

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	49	1,344	$1,044,189
Calquence	Acalabrutinib Maleate	77	2,284	$996,845
Xtandi	Enzalutamide	52	1,560	$755,549
Lenvima	Lenvatinib Mesylate	23	690	$663,446
Lenalidomide	Lenalidomide	39	1,071	$653,542

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0766	Electrical stimulation device used for cancer treatment, includes all accessories, any type	Y	N/R	11	$135,284
B4152	Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	13	$2,908
J8521	Capecitabine, oral, 500 mg	N	N/R	40	$1,300
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	14	33	$621
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	11	22	$263

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	163	$3,067	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	137	$740,253	PFIZER INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jaswinder Singh, MD?

Tedicare shows public-source Medicare data for Jaswinder Singh, MD (NPI 1093747677), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jaswinder Singh, MD have ACO affiliation data?

Jaswinder Singh, MD is shown with ACO affiliation data for Centrus Health LLC (MSSP, ACO ID A5304).

What billing organization is linked to Jaswinder Singh, MD?

Jaswinder Singh, MD is linked to AMERICAN ONCOLOGY PARTNERS PA (billing NPI 1265929723) in the available physician profile data.

Does Jaswinder Singh, MD have Open Payments data?

Jaswinder Singh, MD has 300 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.